Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.53 USD
Change Today 0.00 / 0.00%
Volume 0.0
UNISZ On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Stuttgart
Berlin
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

unilife corp-cdi (UNISZ) Snapshot

Open
$0.53
Previous Close
$0.53
Day High
$0.53
Day Low
$0.53
52 Week High
02/10/15 - $0.76
52 Week Low
09/5/14 - $0.36
Market Cap
417.3M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
787.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for UNILIFE CORP-CDI (UNISZ)

Related News

No related news articles were found.

unilife corp-cdi (UNISZ) Related Businessweek News

View More BusinessWeek News

unilife corp-cdi (UNISZ) Details

Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction. It also provides ReadyToGo platform of wearable injectors designed for pre-filled, disposable devices that can be worn by a patient over periods during the subcutaneous injection of therapies; LISA smart reusable auto-injector; and RITA disposable auto-injector, an ergonomic single-use product. In addition, the company offers drug reconstitution delivery systems, including AutoMix Presto, an automatic reconstitution for single-step mixing and injection; EZMix Genesis, a ventless one-step reconstitution and automatic user-controlled retraction; EZMix Engage, a one step reconstitution to attach and retract a needle; and EZMix Prodigy, a single-barrel reconstitution system with a pre-fillable syringe. Further, it provides ocular delivery systems comprising Ocu-ject for the delivery of microliter sized doses to the eye; Ocu-mix, a dual-chamber syringe platform to reconstitute or mix, and deliver various therapies into the eye with a single injection; and Depot-ject, which places a drug depot into the eye. Additionally, the company offers Micro-ject to optimize the delivery of therapies with microliter doses that are unsuited to conventional device technologies. It serves pharmaceutical and biotechnology companies. The company was founded in 2002 and is headquartered in York, Pennsylvania.

209 Employees
Last Reported Date: 09/15/14
Founded in 2002

unilife corp-cdi (UNISZ) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $630.0K
President and Chief Operating Officer
Total Annual Compensation: $726.0K
Chief Compliance Officer and Vice President o...
Total Annual Compensation: $308.0K
Senior Vice President and Controller
Total Annual Compensation: $308.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $52.3K
Compensation as of Fiscal Year 2014.

unilife corp-cdi (UNISZ) Key Developments

Unilife Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Unilife Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported revenue of $2,921,000 compared to $1,383,000 a year ago. Operating loss was $20,531,000 compared to $14,310,000 a year ago. Net loss was $23,105,000 or $0.20 per basic and diluted share compared to $15,109,000 or $0.15 per basic and diluted share a year ago. Adjusted net loss was $16,265,000 or $0.14 per basic and diluted share compared to $11,670,000 or $0.12 per basic and diluted share a year ago. This increase in adjusted net loss is primarily attributable to increased investment in R&D. For the nine months, the company reported revenue of $9,704,000 compared to $8,143,000 a year ago. Operating loss was $56,094,000 compared to $37,021,000 a year ago. Net loss was $64,754,000 or $0.59 per basic and diluted share compared to $42,636,000 or $0.44 per basic and diluted share a year ago. Adjusted net loss was $44,749,000 or $0.41 per basic and diluted share compared to $27,053,000 or $0.28 per basic and diluted share a year ago.

Unilife Corporation Announces Consolidated Cash Flow Results for the Third Quarter and Nine Months Ended March 31, 2015

Unilife Corporation announced consolidated cash flow results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported net operating cash outflow was $11.619 million and Payment for acquisition of physical non-current assets was $4.627 million. For the nine months, the company reported net operating cash outflow was $37.109 million and Payment for acquisition of physical non-current assets was $11.157 million.

Unilife Corporation to Report Q3, 2015 Results on May 11, 2015

Unilife Corporation announced that they will report Q3, 2015 results at 4:30 PM, US Eastern Standard Time on May 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UNISZ:US $0.53 USD 0.00

UNISZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $140.28 USD -1.66
West Pharmaceutical Services Inc $54.00 USD -1.13
Ypsomed Holding AG SFr.93.35 CHF -0.15
View Industry Companies
 

Industry Analysis

UNISZ

Industry Average

Valuation UNISZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 105.6x
Price/Book 422.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNILIFE CORP-CDI, please visit www.unilife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.